Breaking News Instant updates and real-time market news.

PYPL

PayPal

$91.66

0.24 (0.26%)

16:19
07/25/18
07/25
16:19
07/25/18
16:19

PayPal sees Q3 EPS 53c-55c, consensus 54c

Sees Q3 revenue $3.62B-$3.67B, consensus $3.71B.

  • 25

    Jul

  • 13

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

PYPL PayPal
$91.66

0.24 (0.26%)

07/19/18
FBCO
07/19/18
NO CHANGE
Target $100
FBCO
Outperform
PayPal price target raised to $100 from $93 at Credit Suisse
Credit Suisse analyst Paul Condra raised his price target for PayPal to $100 from $93 as he remains positive on the name and views its unfolding acquisition strategy as strengthening the core merchant platform and expanding the company's value proposition. The analyst views this strategy as helping PayPal to become a partner of choice for merchants while expanding its offering well beyond payment solutions to include a diverse offering of marketing and sales conversion tools as well as financing options. The iZettle acquisition will also extend the company's reach into brick-and-mortar commerce, he contends, while reiterating an Outperform rating on the shares.
07/23/18
FBCO
07/23/18
NO CHANGE
FBCO
Outperform
PayPal has 'unique opportunity' to leverage customer base, says Credit Suisse
Credit Suisse analyst Paul Condra believes PayPal (PYPL) has a "unique opportunity" as merchants are increasingly pressured to find ways to differentiate from Amazon (AMZN). PayPal has not leveraged the customer side of its platform to its full potential, Condra tells investors in an intraday research note titled "PayPal Prime? Considering PYPL's Potential." The analyst argues that PayPal can become much more valuable to both consumers and merchants once it leverages its 200M global user base. He keeps an Outperform rating on the shares.
07/24/18
FBCO
07/24/18
NO CHANGE
Target $100
FBCO
Outperform
PayPal has 'unique' opportunity to leverage position, says Credit Suisse
Credit Suisse analyst Paul Condra is increasingly convinced PayPal (PYPL) has a "unique" opportunity to leverage its position as part of the fabric of the online economy, specifically the non-Amazon (AMZN) economy, to become much more valuable to both consumers and merchants. Condra believes PayPal has not leveraged the customer side of its platform to its full potential. While shoppers use it to pay for things, they do not use it to look for things, and herein lies the opportunity, he contends. The analyst reiterates an Outperform rating and $100 price target on PayPal shares.
07/25/18
KEYB
07/25/18
NO CHANGE
Target $100
KEYB
Overweight
PayPal price target raised to $100 from $95 at KeyBanc
KeyBanc analyst Josh Beck raised his price target for PayPal to $100 from $95 as his consumer survey indicated the preference for checking out with Venmo doubled sequentially. The analyst notes that the new marquee Pay with Venmo partners like Uber and GrubHub alone create a $30B-plus TPV opportunity next year, suggesting Pay with Venmo may be poised to break out. Separately, his Key First Look Data: Consumer Spending points to a modest sequential acceleration in TPV, which would be above Beck's estimate. He reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

, GFI

Gold Fields

$5.51

-0.16 (-2.82%)

07:28
07/23/19
07/23
07:28
07/23/19
07:28
Hot Stocks
Asanko Gold outlines 2H19 exploration program »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

GFI

Gold Fields

$5.51

-0.16 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

, MSFT

Microsoft

$138.41

1.79 (1.31%)

07:27
07/23/19
07/23
07:27
07/23/19
07:27
Initiation
Adaptive Biotechnologies, Microsoft, Roche initiated  »

Adaptive Biotechnologies…

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

MSFT

Microsoft

$138.41

1.79 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

NDAQ

Nasdaq

$101.77

0.05 (0.05%)

07:26
07/23/19
07/23
07:26
07/23/19
07:26
Hot Stocks
Nasdaq signs new agreement with Football Index »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

LII

Lennox

$264.15

-14.91 (-5.34%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$2.56

-0.04 (-1.54%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Sorrento Therapeutics analyst commentary  »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$147.16

1.98 (1.36%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Hershey analyst commentary  »

Hershey price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

INAP

Internap

$2.76

-0.23 (-7.69%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Hot Stocks
Internap launches Intelligent Monitoring managed cloud and monitoring service »

Internap Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$105.16

1.14 (1.10%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Initiation
Silicon Labs initiated  »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 13

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Downgrade
Viveve rating change  »

Mizuho double downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.64

-0.25 (-0.46%)

07:20
07/23/19
07/23
07:20
07/23/19
07:20
Recommendations
Mondelez analyst commentary  »

Mondelez price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

INTC

Intel

$51.36

1.1 (2.19%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Initiation
Intel initiated  »

Intel initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

TORC

ResTORbio

$11.18

1.15 (11.47%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Hot Stocks
ResTORbio completes patient enrollment of Phase 3 PROTECTOR 1 trial »

resTORbio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$264.15

-14.91 (-5.34%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AGTC

Applied Genetic

$3.89

0.02 (0.52%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Hot Stocks
Applied Genetic completes enrollment of third group in Phase 1/2 clinical study »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

PEBO

Peoples Bancorp

$31.80

0.08 (0.25%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Earnings
Peoples Bancorp reports Q2 EPS 46c with items, consensus 68c »

Reports Q2 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Downgrade
Viveve rating change  »

Viveve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$53.30

0.005 (0.01%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Earnings
Rogers Communications reports Q2 adjusted EPS C$1.16 vs. C$1.07 last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

JBT

John Bean Technologies

$121.10

-0.995 (-0.81%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Recommendations
John Bean Technologies analyst commentary  »

John Bean Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Sep

IEX

IDEX Corp.

$164.74

0.31 (0.19%)

07:15
07/23/19
07/23
07:15
07/23/19
07:15
Recommendations
IDEX Corp. analyst commentary  »

IDEX Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ROP

Roper Technologies

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Roper Technologies analyst commentary  »

Roper Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ACAD

Acadia

$25.97

0.28 (1.09%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Acadia analyst commentary  »

Cantor sees failed trial,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

PTI

Proteostasis

$0.89

-0.0209 (-2.31%)

, GLPG

Galapagos

$187.55

4.1 (2.23%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Hot Stocks
Proteostasis appoints Geoffrey Gilmartin as Chief Medical Officer »

Proteostasis Therapeutics…

PTI

Proteostasis

$0.89

-0.0209 (-2.31%)

GLPG

Galapagos

$187.55

4.1 (2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 09

    Sep

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Earnings
RedHill Biopharma reports Q2 EPS (4c), consensus (35c) »

Reports Q2 revenue $1.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

XLNX

Xilinx

$124.24

1.52 (1.24%)

07:12
07/23/19
07/23
07:12
07/23/19
07:12
Initiation
Xilinx initiated  »

Xilinx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 08

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.